Second-generation thienopyridine use is not associated with better early perioperative outcome during carotid stenting

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 2, 2011, Pages 214-221

  De Rango, P ^a   Parlani, G ^a   Romano, L ^a   Verzini, F ^a   Giordano, G ^a   Cieri, E ^a   Barbante, M ^a   Cao, P ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Carotid angioplasty; Carotid stenting; Clopidogrel; Stroke risk; Thienopyridine

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; COMORBIDITY; DEATH; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; SURGICAL RISK; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY; ASYMPTOMATIC DISEASES; CAROTID STENOSIS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79651471046     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.10.007     Document Type: Article

References (20)

1. D.P. Faxon, and J.E. Freedman Facts and controversies of aspirin and clopidogrel therapy Am Heart J 157 2009 412 422
2. G.L. Plosker, and K.A. Lyseng-Williamson Clopidogrel: a review of its use in the prevention of thrombosis Drugs 67 2007 613 646 [Review] (Pubitemid 46442637)
3. Canadian Cardiovascular Society 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines J Am Coll Cardiol 51 2008 210 247
4. L.B. Goldstein, R. Adams, M.J. Alberts, L.J. Appel, L.M. Brass, C.D. Bushnell American Heart Association American Stroke Association Stroke Council Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council Circulation 113 2006 e873 923
5. J. Berg, D. Fidan, and P. Lindgren Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials Curr Med Res Opin 24 2008 2089 2101
6. S.R. Mehta Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE J Invasive Cardiol Suppl. 17B-20B 2003
7. H.C. Diener, J. Bogousslavsky, L.M. Brass, C. Cimminiello, L. Csiba, M. Kaste MATCH investigators Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 331 337 (Pubitemid 38970009)
8. H.S. Markus, D.W. Droste, M. Kaps, V. Larrue, K.R. Lees, and M. Siebler Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial Circulation 111 2005 2233 2240 (Pubitemid 40632440)
9. G.J. Hankey, W. Hacke, J.D. Easton, S.C. Johnston, J.L. Mas, D.M. Brennan CHARISMA Trial Investigators Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial Stroke 41 2010 1679 1683
10. J.A. Beckman Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease? Catheter Cardiovasc Interv 74 2009 S12 S16
11. T.J. Kiernan, B.P. Yan, and M.R. Jaff Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease J Vasc Surg 50 2009 431 439
12. S. Chaturvedi, and J.S. Yadav The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention Stroke 37 2006 1572 1577 (Pubitemid 44305747)
13. F.M. McKevitt, M.S. Randall, T.J. Cleveland, P.A. Gaines, K.T. Tan, and G.S. Venables The benefits of combined anti-platelet treatment in carotid artery stenting Eur J Vasc Endovasc Surg 29 2005 522 527 (Pubitemid 40973849)
14. D. Gortler, F.J. Schlösser, B.E. Muhs, M.A. Nelson, and A. Dardik Periprocedural drug therapy in carotid artery stenting: the need for more evidence Vascular 16 2008 303 309
15. P.D. Hayes, H. Box, S. Tull, P.R. Bell, A. Goodall, and A.R. Naylor Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate J Vasc Surg 38 2003 1226 1231 (Pubitemid 37517650)
16. A. Iancu, C. Grosz, and A. Lazar Acute carotid stent thrombosis: review of the literature and long-term follow-up Cardiovasc Revasc Med 11 2010 110 113
17. C. Setacci, G. de Donato, F. Setacci, E. Chisci, A. Cappelli, and M. Pieraccini Surgical management of acute carotid thrombosis after carotid stenting: a report of three cases J Vasc Surg 42 2005 993 996 (Pubitemid 41571970)
18. G. Paré, S.R. Mehta, S. Yusuf, S.S. Anand, S.J. Connolly, and J. Hirsh Effects of CYP2C19 genotype on outcomes of clopidogrel treatment N Engl J Med 363 2010 1704 1714
19. B.A. Perler The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting Semin Vasc Surg 20 2007 252 258 (Pubitemid 350245577)
20. R.W. Hobson 2nd, V.J. Howard, G.S. Roubin, T.G. Brott, R.D. Ferguson, J.J. Popma CREST Investigators Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase J Vasc Surg 40 2004 1106 1111 (Pubitemid 40044678)